CDKN2A/B Alterations Impair Prognosis in Adult BCR-ABL1-Positive Acute Lymphoblastic Leukemia Patients

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-11-1227
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Γ-Catenin-Dependent Signals Maintain BCR-ABL1+ B Cell Acute Lymphoblastic Leukemia

Cancer Cell
Cancer ResearchOncologyCell Biology
2019English

A Novel BCR-ABL1 Mutation in a Patient With Philadelphia Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia

OncoTargets and Therapy
OncologyPharmacology
2018English

BCR/ABL1 -Like Acute Lymphoblastic Leukemia: How to Diagnose and Treat?

Cancer
Cancer ResearchOncology
2018English

Tyrosine Kinase Fusion Genes in Pediatric BCR-ABL1-like Acute Lymphoblastic Leukemia

Oncotarget
Oncology
2016English

Tyrosine Kinase Inhibitors in BCR-ABL Positive Acute Lymphoblastic Leukemia

Haematologica
Hematology
2015English

Next-Generation Sequencing in Adult B Cell Acute Lymphoblastic Leukemia Patients

Biology of Blood and Marrow Transplantation
TransplantationHematology
2017English

Novel Immunotherapies for Adult Patients With B-Lineage Acute Lymphoblastic Leukemia

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2017English

Failure of CDKN2A/B (INK4A/B-ARF)-mediated Tumor Suppression and Resistance to Targeted Therapy in Acute Lymphoblastic Leukemia Induced by BCR-ABL

Genes and Development
GeneticsDevelopmental Biology
2008English

Adult Acute Lymphoblastic Leukemia

Cancer
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy